Similarly, in breast cancer, FAT4 silencing resulted in the upregulation of N-cadherin, MMP-7, and Cyr61 expression and the downregulation of E cadherin, indicating the role of FAT4 in the EMT process [8]. Here, CDH1 is linked to breast carcinoma.